
    
      Objectives and Study Plan:

      Study Purpose:

      The purpose of the study is to investigate the underlying immunological processes in GCA and
      to study the pattern of expression of immune response over time to give us information about
      how best to monitor GCA.

      End Point:

      The end point will be the final visit of the final patient.

      Milestones:

      The project is in 3 phases. In phase 1 (0-2 years) patients will be recruited to fulfil the
      specified primary and secondary objectives. In phase 2 (0-4 years), these patients will be
      followed up for a total of 2 years each, or until they are discharged from clinic. In phase 3
      (1-5 years), further studies will be defined and tissue and data collected under amended
      ethics.
    
  